Roger Sidhu

Roger Sidhu is a seasoned medical executive with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Chief Medical Officer at Cardiff Oncology, Roger has held prominent leadership roles including Acting CEO and Chief Medical Officer at Treadwell Therapeutics, Inc., and Chief Medical Officer at Brooklyn ImmunoTherapeutics. Roger's tenure at Roivant Sciences as Executive Vice President emphasized research and development, while earlier positions at Kite Pharma, Cell Design Labs, and Amgen showcased significant contributions to clinical development and commercialization in hematology and oncology. An alumnus of the University of Alberta and Queen's University, Roger holds degrees in Biochemistry and Medicine.